share_log

Opsens Inc. (TSE:OPS) to Post FY2026 Earnings of $0.09 Per Share, Raymond James Forecasts

Opsens Inc. (TSE:OPS) to Post FY2026 Earnings of $0.09 Per Share, Raymond James Forecasts

雷蒙德·詹姆斯预测,Opsens Inc.(多伦多证券交易所代码:OPS)将公布2026财年每股收益0.09美元
Defense World ·  2022/07/18 02:31

Opsens Inc. (TSE:OPS – Get Rating) – Research analysts at Raymond James dropped their FY2026 earnings per share estimates for shares of Opsens in a research note issued to investors on Thursday, July 14th. Raymond James analyst R. Sarugaser now forecasts that the company will post earnings of $0.09 per share for the year, down from their prior estimate of $0.10. The consensus estimate for Opsens' current full-year earnings is $0.02 per share.

Opsens Inc.(TSE:OPS-GET Rating)-在7月14日星期四发布给投资者的一份研究报告中,Raymond James的研究分析师下调了对Opsens股票2026财年每股收益的预期。Raymond James分析师R.Sarugaser现在预测,该公司今年的每股收益将为0.09美元,低于此前预测的0.10美元。对Opsens目前全年收益的普遍估计是每股0.02美元。

Get
到达
Opsens
奥普森斯
alerts:
警报:

Separately, Stifel Nicolaus assumed coverage on Opsens in a research report on Wednesday, April 13th. They set a "buy" rating and a C$3.35 price target for the company.

另外,Stifel Nicolaus在4月13日星期三的一份研究报告中对Opsens进行了报道。他们为该公司设定了“买入”评级和3.35加元的目标价。

Opsens Trading Down 2.5 %

Opsens股价下跌2.5%

OPS opened at C$2.30 on Monday. The business has a 50 day simple moving average of C$2.10 and a two-hundred day simple moving average of C$2.09. The firm has a market capitalization of C$250.17 million and a price-to-earnings ratio of -38.98. The company has a debt-to-equity ratio of 14.63, a current ratio of 7.40 and a quick ratio of 6.26. Opsens has a one year low of C$1.55 and a one year high of C$3.74.
Ops周一开盘报2.30加元。该业务的50日简单移动均线切入位在2.10加元,200日简单移动均线切入位在2.09加元。该公司市值为2.5017亿加元,市盈率为-38.98倍。该公司的债务权益比为14.63,流动比率为7.40,速动比率为6.26。Opsens的一年低点为1.55加元,一年高位为3.74加元。

About Opsens

关于奥普森

(Get Rating)

(获取评级)

Opsens Inc develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology.

Opsens Inc.开发、制造、安装和销售用于介入心脏病学、部分血流储备(FFR)、石油和天然气以及工业应用的光纤传感器。该公司在医疗和工业两个领域开展业务。医疗部门主要专注于生理测量,如冠状动脉狭窄市场的FFR和DPR;并提供一系列微型光学传感器,用于测量其他医疗设备中的集成应用中的压力和温度,并获得其光学传感器技术的许可。

Recommended Stories

推荐故事

  • Financial services firm Block stock has fallen (-59%) in 2022
  • Hold Pfizer Today With Catalysts for Further Growth Tomorrow
  • NVIDIA Stock is a Winding Up for a Record Setting Second Half
  • Johnson & Johnson Continues to Prove its Value in a Volatile Year
  • MarketBeat: Week in Review 7/11 – 7/15
  • 金融服务公司Block股价在2022年下跌(-59%)
  • 今天持有辉瑞公司的催化剂,明天就能实现进一步增长
  • NVIDIA股票将在下半年创下纪录
  • 强生在动荡的一年里继续证明自己的价值
  • MarketBeat:回顾一周7/11-7/15

Receive News & Ratings for Opsens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opsens and related companies with MarketBeat.com's FREE daily email newsletter.

接受Opsens Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Opsens和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发